EcoDrugPlus

Aldo-Keto Reductase Family 1 Member B10-Like

Ensembl ID : ENSSFOG00015023333
Gene Symbol: LOC108920994
3 Cross references
346 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSSFOG00015027922
Gene Symbol: AKR1B1.2
1 Cross references
343 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSSFOG00015003199
Gene Symbol: GAA
1 Cross references
234 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSSFOG00015029758
Gene Symbol: LOC108934154
2 Cross references
196 Possible Orthologues:

Alpha-1d Adrenergic Receptor-Like

Ensembl ID : ENSSFOG00015017102
Gene Symbol: LOC108926014
2 Cross references
3 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSSFOG00015032553
Gene Symbol: LOC108940308
3 Cross references
174 Possible Orthologues:

Alpha-Synuclein

Ensembl ID : ENSSFOG00015010103
Gene Symbol: LOC108929549
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSSFOG00015009863
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amylase Alpha 1c

Ensembl ID : ENSSFOG00015008070
Gene Symbol: AMY1C
3 Cross references
213 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSSFOG00015008854
Gene Symbol: APP
3 Cross references
134 Possible Orthologues:

Amyloid-Beta A4 Protein-Like

Ensembl ID : ENSSFOG00015016010
Gene Symbol: LOC108931713
2 Cross references
204 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSSFOG00015008484
Gene Symbol: AR
3 Cross references
277 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).